Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway

F Zhou1, Y Tan, X-H Chen

  • 1Department of Neurology, The Third Affiliated Hospital of Nanchang University, Nanchang, China. wuxm79@163.com.

Abstract

Insights

Atorvastatin enhances plaque stability in diabetic atherosclerosis by reducing lipid deposition and inflammation. This study shows atorvastatin improves arterial health via the receptor for advanced glycation end products (RAGE) pathway.

Area of Science:

  • Cardiovascular Research
  • Diabetes Mellitus Research
  • Pharmacology

Background:

  • Diabetes mellitus (DM) significantly increases the risk of atherosclerosis.
  • Diabetic atherosclerosis is characterized by plaque instability, lipid deposition, and inflammation.
  • Atorvastatin is a statin drug with potential pleiotropic effects beyond lipid lowering.

Purpose of the Study:

  • To investigate the therapeutic effects of atorvastatin on atherosclerotic plaque stability in a mouse model of diabetes mellitus.
  • To elucidate the underlying mechanisms by which atorvastatin influences plaque composition and stability in diabetic atherosclerosis.

Main Methods:

  • Apolipoprotein E knockout mice were used to establish a combined model of diabetes mellitus and atherosclerosis.
  • Histological analyses (Oil red O, Masson staining) were performed to assess lipid and collagen content.
  • Immunohistochemistry and Western blotting were employed to evaluate protein expression, including smooth muscle cells, macrophages, RAGE, MCP-1, and NF-κB.
  • Serum biomarkers such as AGEs, sRAGE, MDA, and GSH were measured.

Main Results:

  • Atorvastatin treatment significantly reduced atherosclerotic plaque area and improved plaque stability.
  • Key improvements included decreased lipid deposition, reduced macrophage and smooth muscle cell infiltration, and increased collagen content.
  • Atorvastatin administration led to decreased serum levels of advanced glycation end products (AGEs) and soluble receptor for advanced glycation end products (sRAGE).
  • The drug inhibited the RAGE signaling pathway and reduced oxidative stress markers.

Conclusions:

  • Atorvastatin effectively improves plaque stability in the context of diabetic atherosclerosis.
  • The beneficial effects are mediated, at least in part, through modulation of the receptor for advanced glycation end products (RAGE) pathway.
  • Atorvastatin's action involves reducing lipid accumulation, inflammation, and oxidative stress, thereby stabilizing atherosclerotic lesions.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
446
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.2K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
6.7K
Nuclear Stability03:18

Nuclear Stability

Protons and neutrons, collectively called nucleons, are packed together tightly in a nucleus. With a radius of about 10−15 meters, a nucleus is quite small compared to the radius of the entire atom, which is about 10−10 meters. Nuclei are extremely dense compared to bulk matter, averaging 1.8 × 1014 grams per cubic centimeter. If the earth’s density were equal to the average nuclear density, the earth’s radius would be only about 200 meters.
To hold positively charged protons together...
23.4K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K